3.845
price up icon4.48%   0.165
 
loading
Evoke Pharma Inc stock is traded at $3.845, with a volume of 13,349. It is up +4.48% in the last 24 hours and down -28.80% over the past month. Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
See More
Previous Close:
$3.68
Open:
$3.8
24h Volume:
13,349
Relative Volume:
0.74
Market Cap:
$5.71M
Revenue:
$8.62M
Net Income/Loss:
$-6.15M
P/E Ratio:
-0.3486
EPS:
-11.03
Net Cash Flow:
$-5.32M
1W Performance:
-4.92%
1M Performance:
-28.80%
6M Performance:
-10.79%
1Y Performance:
-50.01%
1-Day Range:
Value
$3.67
$3.9107
1-Week Range:
Value
$3.60
$4.04
52-Week Range:
Value
$3.44
$12.32

Evoke Pharma Inc Stock (EVOK) Company Profile

Name
Name
Evoke Pharma Inc
Name
Phone
858-345-1494
Name
Address
420 STEVENS AVENUE, SOLANA BEACH, CA
Name
Employee
4
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
EVOK's Discussions on Twitter

Compare EVOK with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
EVOK
Evoke Pharma Inc
3.845 5.71M 8.62M -6.15M -5.32M -11.03
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
160.06 71.67B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.03 47.44B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.19 46.08B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.46 18.86B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
ITCI
Intra Cellular Therapies Inc
131.36 13.97B 612.78M -86.37M -62.91M -0.87

Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-22-20 Upgrade H.C. Wainwright Neutral → Buy
Mar-05-19 Downgrade H.C. Wainwright Buy → Neutral
Mar-08-18 Reiterated B. Riley FBR, Inc. Buy
Oct-19-17 Resumed FBR & Co. Buy
Mar-16-17 Reiterated Rodman & Renshaw Buy
Jan-30-17 Upgrade Laidlaw Neutral → Buy
Jan-05-17 Upgrade Rodman & Renshaw Neutral → Buy
Dec-23-16 Reiterated Rodman & Renshaw Neutral
Jul-19-16 Reiterated FBR Capital Outperform
Jul-19-16 Downgrade Noble Financial Buy → Hold
Jul-18-16 Downgrade Rodman & Renshaw Buy → Neutral
Mar-16-16 Initiated Northland Capital Outperform
Mar-14-16 Reiterated Ascendiant Capital Markets Buy
Feb-17-16 Resumed FBR Capital Outperform
Dec-03-14 Reiterated MLV & Co Buy
Nov-07-14 Initiated MLV & Co Buy
Apr-22-14 Initiated Laidlaw Buy
Nov-19-13 Initiated Aegis Capital Buy
View All

Evoke Pharma Inc Stock (EVOK) Latest News

pulisher
03:09 AM

Evoke Pharma Inc (EVOK) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Plans - Yahoo Canada Finance

03:09 AM
pulisher
02:24 AM

Evoke Pharma Reports Strong Revenue Growth in 2024 - TipRanks

02:24 AM
pulisher
Mar 13, 2025

Earnings call transcript: Evoke Pharma Q4 2024 reports strong sales growth - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

Evoke Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

EVOKE PHARMA Earnings Results: $EVOK Reports Quarterly Earnings - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Evoke Pharma, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times

Mar 13, 2025
pulisher
Mar 13, 2025

The Canada Foundation for Innovation supports Canada Research Chairs with nearly $4.4 million investment in research infrastructure - The Manila Times

Mar 13, 2025
pulisher
Mar 13, 2025

Earnings Scheduled For March 13, 2025 - Benzinga

Mar 13, 2025
pulisher
Mar 12, 2025

StockNews.com Begins Coverage on Evoke Pharma (NASDAQ:EVOK) - Defense World

Mar 12, 2025
pulisher
Mar 10, 2025

Gastroparesis Treatment Market Poised for Substantial Growth - openPR

Mar 10, 2025
pulisher
Mar 06, 2025

Evoke Pharma to Report Fourth Quarter and Full Year 2024 Results on March 13, 2025 - GlobeNewswire

Mar 06, 2025
pulisher
Mar 06, 2025

Evoke Pharma, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025 - Nasdaq

Mar 06, 2025
pulisher
Mar 06, 2025

When Will Evoke Pharma Share Its Latest Gimoti Sales Numbers? - StockTitan

Mar 06, 2025
pulisher
Mar 05, 2025

Evoke Pharma (EVOK) to Release Quarterly Earnings on Wednesday - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Sanctuary Advisors LLC Sells 40,570 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK) - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Shares Sold by Sanctuary Advisors LLC - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Sanctuary Advisors LLC - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Evoke Pharma (NASDAQ:EVOK) Stock Crosses Below 200 Day Moving Average – Should You Sell? - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Alliance Bioenergy Plus (OTCMKTS:ALLM) Shares Cross Below 200 Day Moving Average – Time to Sell? - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

Evoke Pharma stock hits 52-week low at $3.49 amid challenges - Investing.com India

Mar 03, 2025
pulisher
Mar 03, 2025

Evoke Pharma stock hits 52-week low at $3.49 amid challenges By Investing.com - Investing.com South Africa

Mar 03, 2025
pulisher
Mar 01, 2025

Evoke Pharma, Inc. to Host Earnings Call - ACCESS Newswire

Mar 01, 2025
pulisher
Feb 27, 2025

Investor Network: Evoke Pharma, Inc. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

Gastroparesis Drugs Market Forecast: Insights, Trends & Key - openPR

Feb 27, 2025
pulisher
Feb 26, 2025

Diabetic Gastroparesis Treatment Market Future Business - openPR

Feb 26, 2025
pulisher
Feb 25, 2025

Evoke Pharma (NASDAQ:EVOK) Now Covered by Analysts at StockNews.com - Armenian Reporter

Feb 25, 2025
pulisher
Feb 24, 2025

Evoke Pharma adds pharma veteran to its board - Investing.com

Feb 24, 2025
pulisher
Feb 24, 2025

Evoke Pharma adds pharma veteran to its board By Investing.com - Investing.com South Africa

Feb 24, 2025
pulisher
Feb 24, 2025

Evoke Pharma appoints new director Greg Pyszcymuka - Investing.com

Feb 24, 2025
pulisher
Feb 24, 2025

5 Top AI Stocks I'm Buying on the Dip - The Globe and Mail

Feb 24, 2025
pulisher
Feb 24, 2025

Evoke Pharma appoints new director Greg Pyszcymuka By Investing.com - Investing.com South Africa

Feb 24, 2025
pulisher
Feb 24, 2025

Evoke Pharma, Inc. Appoints Greg Pyszczymuka to Board of Directors, Strengthening Commercial Strategy - Nasdaq

Feb 24, 2025
pulisher
Feb 24, 2025

Evoke Pharma Announces the Appointment of Greg Pyszczymuka to the Board of Directors - GlobeNewswire

Feb 24, 2025
pulisher
Feb 24, 2025

Can This New Board Member Transform Evoke Pharma's Commercial Success? - StockTitan

Feb 24, 2025
pulisher
Feb 24, 2025

(EVOK) Investment Analysis and Advice - Stock Traders Daily

Feb 24, 2025
pulisher
Feb 24, 2025

Geriatric Medicines Market Poised for Significant Expansion | - openPR

Feb 24, 2025
pulisher
Feb 24, 2025

Gastric Motility Disorder Drug Market Witnessing High Demand | - openPR

Feb 24, 2025
pulisher
Feb 24, 2025

Evoke Pharma (NASDAQ:EVOK) Coverage Initiated by Analysts at StockNews.com - Defense World

Feb 24, 2025
pulisher
Feb 21, 2025

Gastroparesis Drugs Market: $6,662.35 Million by 2032, 4.4% CAGR - openPR

Feb 21, 2025
pulisher
Feb 17, 2025

Gastroparesis Treatment Market Generated Opportunities, - openPR

Feb 17, 2025
pulisher
Feb 17, 2025

Evoke Pharma (NASDAQ:EVOK) Now Covered by StockNews.com - Defense World

Feb 17, 2025
pulisher
Feb 14, 2025

Loss-Making Evoke Pharma, Inc. (NASDAQ:EVOK) Set To Breakeven - Simply Wall St

Feb 14, 2025
pulisher
Feb 08, 2025

Research Analysts’ New Coverage for February 8th (AC, APT, ARL, BIOL, CCRN, CNET, EDAP, ENLC, ENSV, ESGR) - Armenian Reporter

Feb 08, 2025
pulisher
Feb 06, 2025

Gastroparesis Market Expected to rise, 2034 | Vanda - openPR

Feb 06, 2025
pulisher
Feb 04, 2025

Nantahala Capital Management, LLC Increases Stake in Evoke Pharm - GuruFocus.com

Feb 04, 2025
pulisher
Jan 31, 2025

Evoke Pharma (NASDAQ:EVOK) Stock Crosses Below 200 Day Moving Average – Here’s What Happened - Defense World

Jan 31, 2025
pulisher
Jan 31, 2025

StockNews.com Initiates Coverage on Evoke Pharma (NASDAQ:EVOK) - Defense World

Jan 31, 2025
pulisher
Jan 30, 2025

Nantahala Capital Management, LLC Reduces Stake in Evoke Pharma Inc - GuruFocus.com

Jan 30, 2025
pulisher
Jan 29, 2025

Trane Technologies (TT) Reports Q4: Everything You Need To Know Ahead Of Earnings - The Globe and Mail

Jan 29, 2025
pulisher
Jan 28, 2025

VF Corp (VFC) Reports Q4: Everything You Need To Know Ahead Of Earnings - The Globe and Mail

Jan 28, 2025

Evoke Pharma Inc Stock (EVOK) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$10.31
price down icon 0.77%
$33.62
price up icon 0.63%
$99.29
price down icon 1.55%
$8.98
price down icon 2.81%
$108.99
price down icon 0.07%
$131.36
price up icon 0.08%
Cap:     |  Volume (24h):